Author Index Vol. 19,1996
R. Parwaresch, B. Bültmann, T. Wiegel, Wolfgang E. Berdel(University Hospital Münster), D. Comely, E. Dühmke, K. Mross, C. Degner, M. Lehnert(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ursula Vogel, Katharina Holstein, T.M.M. de Reijke, M. Schiebe, I.-M. von Broen, A. Korfel, Michélle Busch, D.K. Hossfeld, N. Runkel, Kathryn L Herbst, W. H. Hoffmann, K. H. Kurth, H.J. Weh, T. Franke, D. H. J. Schamhart, Elizabeth C. de Boer, T.A. Walter, P. Rudolph, Y. Bankmann, M. Bamberg(Universitätsklinikum Tübingen), Margret Rave‐Fränk
Cited by 0
Related Papers
Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
|Clinical Cancer Research|2015|799
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
|Journal of Clinical Oncology|2005|654